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P-Cadherin Regulates Human Hair Growth
and Cycling via Canonical Wnt Signaling and
Transforming Growth Factor-b2
Liat Samuelov1,2, Eli Sprecher1,3, Daisuke Tsuruta4, Tama´s Bı´ro´5, Jennifer E. Kloepper2,7 and Ralf Paus2,6,7
P-cadherin is a key component of epithelial adherens junctions, and it is prominently expressed in the hair
follicle (HF) matrix. Loss-of-function mutations in CDH3, which encodes P-cadherin, result in hypotrichosis with
juvenile macular dystrophy (HJMD), an autosomal recessive disorder featuring sparse and short hair. Here, we
attempted to recapitulate some aspects of HJMD in vitro by transfecting normal, organ-cultured human scalp
HFs with lipofectamine and CDH3-specific or scrambled control siRNAs. As in HJMD patients, P-cadherin
silencing inhibited hair shaft growth, prematurely induced HF regression (catagen), and inhibited hair matrix
keratinocyte proliferation. In situ, membrane b-catenin expression and transcription of the b-catenin target
gene, axin2, were significantly reduced, whereas glycogen synthase kinase 3 b (GSK3b) and phospho-b-catenin
immunoreactivity were increased. These effects were partially reversed by inhibiting GSK3b. P-cadherin
silencing reduced the expression of the anagen-promoting growth factor, IGF-1, whereas that of transforming
growth factor b 2 (TGFb2; catagen promoter) was enhanced. Neutralizing TGFb antagonized the catagen-
promoting effects of P-cadherin silencing. In summary, we introduce human HFs as an attractive preclinical
model for studying the functions of P-cadherin in human epithelial biology and pathology. This model
demonstrates that cadherins can be successfully knocked down in an intact human organ in vitro, and shows
that P-cadherin is needed for anagen maintenance by regulating canonical Wnt signaling and suppressing
TGFb2.
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INTRODUCTION
P-cadherin is a member of the classical cadherin family and a
key component of adherens junctions in various epithelia,
including the epidermis and hair follicles (HFs; Shimoyama
et al., 1989; Andl et al., 2002; Paredes et al., 2007). It has
major roles in cell recognition and signaling, morphogenesis,
and tumor development (Goodwin and Yap, 2004; Paredes
et al., 2007; Fanelli et al., 2008). It comprises five
extracellular domains, a transmembrane domain, and a small
intracellular domain that interacts with b-catenin. The latter is
a crucial factor in the canonical Wnt signaling pathway
(Nelson and Nusse, 2004; Fanelli et al., 2008; Heuberger
and Birchmeier, 2010; for details, see Figure 1a). As p63
directly interacts with the promoter for CDH3, the gene
that encodes P-cadherin, the latter is a p63 target gene
(Shimomura et al., 2008).
CDH3 mutations cause two autosomal recessive disorders,
hypotrichosis with juvenile macular dystrophy (HJMD;OMIM
601553) and ectodermal dysplasia, ectrodactyly and macular
dystrophy (EEM;OMIM 225280), which are associated with
hair abnormalities. Dermatologically, these patients show
sparse and short hair throughout life, an increased percentage
of HFs in the regression (catagen) or resting stage (telogen) of
the hair cycle, and abnormal hair shafts (Supplementary
Figure S1a–d online; Sprecher et al., 2001; Indelman et al.,
2002, 2007; Bergman et al., 2004; Kjaer et al., 2005; Leibu
et al., 2006; Shimomura et al., 2008, 2010; Jelani et al.,
2009). Although this suggests that P-cadherin is required for
normal hair growth, it remains unknown how P-cadherin
impacts the human HFs. Unfortunately, P-cadherin-deficient
mice fail to recapitulate the HJMD phenotype (Radice et al.,
1997). This suggests that the role of P-cadherin-mediated
signaling in human epithelial biology and pathology is best
studied directly in human HFs.
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To do so, we have generated a previously unreported,
widely accessible in vitro-surrogate model of HJMD, based
on the use of organ-cultured human scalp HFs, a prototypic
ectodermal–mesodermal interaction unit (Paus and Cotsar-
elis, 1999; Schneider et al., 2009). Although, evidently, a
complex human genetic disorder cannot be expected to
be fully recreated in vitro, we hoped that such an in vitro
model could shed new light on how the hair phenotype
develops in HJMD patients and on the as yet obscure role of
P-cadherin signaling in human epithelial biology. Specifi-
cally, we asked how P-cadherin silencing in organ-cultured
human HFs affects hair growth, cycling, and hair shaft
formation. In addition, we aimed to obtain indications as to
which signaling pathway(s) P-cadherin may use to mediate its
HF effects.
RESULTS
P-cadherin expression is strongest in the innermost hair matrix
of human anagen HFs
First, we established the protein expression pattern of
P-cadherin in fully growing human HFs (i.e., in the anagen
VI stage of the hair cycle). Immunohistology showed that, just
as in mice (Muller-Rover et al., 1999), P-cadherin protein is
most prominently expressed in the innermost cell layer of the
human hair matrix (Figure 2a). This confirms the intrafolli-
cular P-cadherin expression pattern previously described
by Fujita et al. (1992). However, prominent P-cadherin
immunoreactivity was also seen throughout the human
epidermis, with sharply reduced expression in its proliferation
compartment, i.e., the basal layer of the epidermis (Supple-
mentary Figure S2a online). This is in contrast with previous
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Figure 2. Constitutive P-cadherin expression and P-cadherin knockdown in normal human hair follicles (HFs). (a) P-cadherin immunoreactivity
(IR; red) in anagen VI human HF. (b) Significantly reduced CDH3 transcript steady-state levels in catagen HFs (RNA from anagen and catagen HFs, cultured for 8
days). **Po0.01, Student’s t test for unpaired samples. (c–e) P-cadherin knockdown: IR is reduced in the innermost hair matrix (IHM) and outer root sheath
(ORS) of P-cadherin siRNA-treated HFs. (e) Data were pooled from two highly comparable, independent experiments. (c) Dotted lines represent reference
areas of measurement. ***Po0.001, Mann–Whitney test, n¼17–23. (f) Reduced CDH3 mRNA level in P-cadherin siRNA-treated HFs. **Po0.01, Student’s
t test for unpaired samples. (g, h) Hair cycle staging was assessed by Ki-67 staining and quantitative Masson–Fontana histochemistry. Data are presented
as hair cycle score (HCS; score represents the mean hair cycle stage of all HFs per treatment group). ***Po0.0001, Mann–Whitney test. (i–l) Significantly
higher keratinocyte proliferation in HFs treated with (i, k, and l) scrambled oligos, compared with (j, k, and l) P-cadherin siRNA-treated HFs. Only anagen HFs
(n¼11–18) and also anagen and catagen HFs (n¼ 20–21) were counted below Auber’s line (dotted line). ***Po0.001, Mann–Whitney test. DP, dermal papilla;
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reports in both mice and humans that state that P-cadherin
expression is largely confined to the epidermal basal layer
(Hirai et al., 1989; Fujita et al., 1992).
P-cadherin expression declines during catagen
As hair cycle–dependent changes in the expression level of
molecules during the HF transformation from growth (ana-
gen) to apoptosis-driven HF regression (catagen) frequently
indicate a functional role of the molecule under investigation
during this organ transformation process (Stenn and Paus,
2001; Schneider et al., 2009), we also examined whether
constitutive P-cadherin expression differs between human
anagen VI and catagen HFs. Indeed, P-cadherin expression
sharply declines during spontaneous, apoptosis-driven HF
regression (catagen), both at the protein (Supplementary
Figure S2b–c online) and transcript steady state (Figure 2b)
levels. This regulated, hair cycle–dependent intrafollicular
P-cadherin expression pattern suggests a functional role for
P-cadherin during the anagen–catagen transformation, the
clinically most important phase in HF cycling (Paus and
Foitzik, 2004; Schneider et al., 2009).
P-cadherin knockdown is possible in human HFs and human
skin organ culture
Next, we attempted to silence P-cadherin expression in
organ-cultured human anagen scalp HFs (Kloepper et al.,
2010) and full-thickness human scalp skin fragments
(Lu et al., 2007). P-cadherin gene knockdown was performed
by transfection with CDH3-specific or scrambled control
siRNAs, using lipofectamine. Successful in situ knockdown of
P-cadherin was documented at the gene and protein levels in
both organ-cultured human scalp HFs (Figure 2c–f) and the
epidermis (Supplementary Figure S2d–g online). No signifi-
cant difference in E-cadherin expression was documented
following P-cadherin knockdown, indicating the specificity
of silencing (Supplementary Figure S2h–j).
To the best of our knowledge, successful knockdown of a
cadherin family member in an intact human organ
has not previously been reported. This invites exploitation
of organ-cultured human HFs and skin as attractive pre-
clinical models for dissecting the molecular and cellular
consequences of P-cadherin loss of function in situ. Avail-
ability of such an experimental model constitutes a significant
methodological advance, as the functions of P-cadherin
mediated signaling in human epithelial physiology are as yet
ill-understood (Faraldo et al., 2007; Shimomura et al., 2008;
Bandara et al., 2010; Jacobs et al., 2011).
P-cadherin silencing results in premature catagen induction and
hair growth inhibition
As the prominent clinical and histological features of HJMD
patients are short and sparse hair since birth, associated with
miniaturization and telogen HFs (Supplementary Figure
S1a–d), we next examined whether P-cadherin knockdown
results in any changes of human hair growth and/or cycling.
As assessed by quantitative hair cycle histomorphometry
and Ki-67 immunohistomorphometry, this was the case:
in vitro P-cadherin knockdown prematurely induced catagen
development in microdissected organ-cultured human ana-
gen VI scalp HFs (Figure 2g–l). This was independently
confirmed by quantitative Masson–Fontana histochemistry
(Kloepper et al., 2010), which revealed the expected sharp
reduction in the HF melanin content (data not shown) as a
result of the catagen-associated switch-off of intrafollicular
melanogenesis (Slominski et al., 2005). Furthermore, P-
cadherin silencing in vitro resulted in significant inhibition
of hair shaft growth (Figure 3).
Therefore, P-cadherin knockdown in healthy human scalp
HFs in vitro partially recapitulates the hair growth inhibition
that is seen in HJMD patients with mutated CDH3 in vivo
(Sprecher et al., 2001). This was associated with a significant
inhibition of hair matrix keratinocyte proliferation in catagen
and anagen HFs (see Figure 2k–l), which explains the reduced
rate of hair shaft formation and is in line with the observed
premature catagen development in P-cadherin-silenced
human HFs.
Ultrastructurally, P-cadherin silencing causes HF dystrophy
The hair growth inhibitory effect of P-cadherin silencing
in situ was followed up at the ultrastructural level. Transmis-
sion electron microscopy showed that, compared with
scrambled-control-treated HFs, P-cadherin-silenced HFs con-
tain large, abnormal aggregates of keratin clumps inside the
cytoplasm of precortical hair matrix keratinocytes (Supple-
mentary Figure S3a–b online), whereas no ultrastructural
abnormalities were detected in the hair shaft cortex and
medulla, except for narrower intercellular spaces (Supple-
mentary Figure S3c–f online).
Quantitative TUNEL immunohistomorphometry showed
that the number of apoptotic keratinocytes in the precortical
hair matrix is not significantly higher than that in control HFs
treated with scrambled oligos (data not shown). Therefore,
the observed keratin clumping phenomenon suggests a defect
in the correct intracellular transport and arrangement of
keratin filaments in the absence of adequate P-cadherin
levels/signaling, and is unlikely to result indirectly from
enhanced, catagen-associated hair matrix keratinocyte apop-
tosis. The concept of a defect in keratin transport and
arrangement is also in line with the observed HF dystrophy
and reduced hair shaft formation.
P-cadherin silencing impairs normal hair keratin expression
To obtain additional pointers to how P-cadherin silencing
may impair hair shaft formation and may cause HF dystrophy,
gene expression profiling was performed. Q-PCR analysis
revealed that three different hair keratins (KRT36, KRT37, and
KRT84) are significantly upregulated by P-cadherin silencing
(Supplementary Figure S4a–c online). Although this remains
to be functionally tested, this abnormal hair keratin expres-
sion profile may relate to the observed hair shaft inhibition
in vitro (Figure 3) and/or to the abnormal hair phenotype seen
in HJMD patients in vivo (Supplementary Figure S1a–b
online; Sprecher et al., 2001; Bergman et al., 2004). These
transcriptional observations, which need to be confirmed
on the protein level, make it conceivable that, in the absence
of functional P-cadherin signaling, overexpression and/or
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miscombination of selected hair shaft keratins can impair hair
shaft structure and resilience.
P-cadherin silencing affects the expression of prominent hair
cycle regulators
Subsequently, we explored whether the P-cadherin silencin-
g–induced hair cycle abnormality goes along with changes in
two key hair cycle regulatory growth factors, i.e., insulin-like
growth factor-1(IGF-1) and transforming growth factor b 2
(TGFb2; Philpott et al., 1994; Stenn and Paus, 2001; Soma
et al., 2002; Hibino and Nishiyama, 2004; Weger and Schlake,
2005; Schneider et al., 2009). The steady-state mRNA level of
IGF-1, the key growth factor that maintains HFs in anagen
(Philpott et al., 1994; Ben Amitai et al., 2006; Kwack et al.,
2009; Zhao et al., 2011), significantly declines after P-cadherin
knockdown (Figure 4a).
In contrast, the immunoreactivity of TGFb2, the key
catagen-inducing growth factor (Hibino and Nishiyama,
2004), significantly increases in P-cadherin-silenced HFs
(Figure 4b–d). This TGFb upregulation is functionally
important, as the effects of P-cadherin knockdown on HF
growth and cycling can be partially reversed by culturing
P-cadherin-silenced HFs in the presence of TGFb-neutraliz-
ing antibody (Supplementary Figure S5a–d online). Thus,
P-cadherin-mediated signaling may be required to maintain
human HFs in anagen, at least in part, via suppressing
TGFb2 expression and by maintaining sufficient IGF-1
levels.
P-cadherin silencing regulates canonical Wnt signaling
P-cadherin and the Wnt signaling pathway rely on the same
pool of cytoplasmic b-catenin (Gottardi and Gumbiner, 2001;
Kuphal and Behrens, 2006; Heuberger and Birchmeier, 2010;
Figure 1a), and adequate Wnt signaling is thought to be
important for anagen maintenance in murine HFs (Van Mater
et al., 2003; Shimizu and Morgan, 2004; Schneider et al.,
2009; Li et al., 2011). Therefore, we finally investigated
whether P-cadherin silencing affects b-catenin stabilization
and Wnt target gene expression in human keratinocytes of the
innermost hair matrix, i.e., the site of maximal intrafollicular
P-cadherin expression (see Figure 2a). To this end, b-catenin
and glycogen synthase kinase 3 b (GSK3b) expression was
assessed immunohistologically.
After intrafollicular P-cadherin silencing, membrane
b-catenin immunoreactivity is significantly reduced, whereas
GSK3b and phospho-b-catenin protein expression is signifi-
cantly increased in situ (Figure 5a–g). Therefore, P-cadherin
silencing in keratinocyes of the innermost hair marix
significantly upregulates b-catenin degradation, likely
through GSK3b. This is expected to result in reduced active
b-catenin available for the Wnt signaling pathway (Figure
1b). Further evidence of reduced b-catenin activity by P-
cadherin knockdown was obtained by demonstrating that
transcription of a key b-catenin target gene, axin 2 (Lovatt and
Bijlmakers, 2010), is reduced in silenced HFs (Figure 5h).
These effects (i.e., axin2 downregulation and phospho-b-
catenin upregulation following P-cadherin knockdown) are
partially reversed by culturing P-cadherin-silenced HFs in the
presence of the potent GSK3b inhibitor, lithium chloride
(Tighe et al., 2007; Figure 5i–k).
Taken together, these experiments demonstrate P-cadherin
to be a key regulator of canonical Wnt signaling in human
HFs, whose maintenance appears to be critical for sustaining
HFs in their growth phase (anagen).
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DISCUSSION
Here we provide early evidence that P-cadherin protein
expression and its presence in adherens junctions is essential
for normal epithelial growth in an intact human organ.
Specifically, we document that P-cadherin operates as a
potent regulator of human hair shaft formation and hair
growth. It has not been shown directly before that a member
of the cadherin family has an essential regulatory role in the
control of normal human HF growth and cycling.
Our data suggest that P-cadherin maintains human HFs in
anagen through activation of canonical Wnt signaling and
operates as a major molecular brake on HF regression
(catagen) by inhibiting GSK3b-mediated b-catenin degrada-
tion, thereby ensuring active canonical Wnt signaling (Figure
1a). This is well in line with the increasing recognition that
canonical Wnt signaling is crucial for murine hair growth
(Huelsken et al., 2001; Andl et al., 2002; Millar, 2002; Van
Mater et al., 2003; Shimizu and Morgan, 2004; Schneider
et al., 2009; Baker et al., 2010; Li et al., 2011). This concept is
supported by our findings that P-cadherin maintains expres-
sion of the anagen-promoting growth factor IGF-1, whereas it
suppresses the chief catagen-promoting growth factor TGFb2.
The current experiments suggest that if normal P-cadherin-
mediated signaling is antagonized by gene silencing, or
becomes dysfunctional owing to CDH3 gene mutations
(HJMD), this results in a decrease of membrane-bound b-
catenin. The latter is likely released from the cadherin–catenin
complex in hair matrix keratinocytes and is targeted for
ubiquitination and degradation, as attested by the observed
upregulation of GSK3b and phospho-b-catenin after P-
cadherin silencing. This, in turn, is expected to sharply reduce
the amount of cytoplasmic b-catenin available for canonical
Wnt signaling, thus resulting in the downregulation of key b-
catenin target genes required for anagen maintenance (for
details, see Figure 1b) (Huelsken et al., 2001; Andl et al.,
2002; Schneider et al., 2009; Baker et al., 2010).
P-cadherin knockdown did not reveal any significant
change of intraepidermal b-catenin expression, compared
with human skin fragments treated with scrambled oligos
(Supplementary Figure S6 online). This suggests that the
effects of P-cadherin silencing on b-catenin (and Wnt
signaling) are HF specific and do not necessarily apply to
other compartments of the human skin epithelium that
normally express P-cadherin (Supplementary Figure S2a
online). The principle that cadherin family members can
impact Wnt activity is further supported by recent studies that
demonstrate that in vivo knockdown of N-cadherin reduces b-
catenin signaling and that E-cadherin depletion diminishes
Wnt-related transcriptional activity (Casagolda et al., 2010;
Zhang et al., 2010; Howard et al., 2011).
Although it is extremely difficult to obtain sufficient
amounts of human HFs to permit western blot analyses of
inner hair matrix proteins, the latter would be desirable to
independently confirm the quantitative immunohistomorpho-
metry in situ data on phospho-b-catenin presented here by
quantitative biochemical evidence.
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The observed keratin clumping (Supplementary Figure S3a
online) may result from defective intracellular transport and
arrangement of keratin filaments in the absence of adequate
P-cadherin levels/signaling. This fits well to the observed HF
dystrophy and reduced hair shaft formation, and is in line
with the concept that P-cadherin is a direct p63 target gene
(Shimomura et al., 2008), as p63 constitutes a crucial control
of normal keratinization (Kim et al., 2009; Mikkola et al.,
2010). Perhaps this p63 connection also explains the
abnormal hair keratin gene expression seen after P-cadherin
silencing (Supplementary Figure S4a–c online).
Just as in murine HFs (Muller-Rover et al., 1998), P-
cadherin is the only classical cadherin that is physiologically
expressed in the innermost hair matrix, i.e., at the key
epithelial interface with the inductive HF mesenchyme
(Figure 2a, Supplementary Figure S2h–j online). Therefore, it
is conceivable that this special epithelial HF compartment
depends on adequate P-cadherin signaling for normal
epithelial cell function and anagen maintenance. This may
render hair matrix keratinocyte proliferation, terminal kera-
tinocyte differentiation in the precortical hair matrix, and
consequently hair shaft formation from this cell pool very
sensitive to P-cadherin silencing and P-cadherin genetic
dysfunction.
Our data also suggest that the innermost cell layer of the
matrix has the capacity to regulate the human hair cycle
independently of epithelial stem cells in the—much more
distally located—HF bulge (which is absent under the current
HF organ culture conditions). Therefore, this region of the hair
matrix must generate as yet unknown P-cadherin-dependent
signals that impact on whether a HF stays in anagen or enters
into catagen and which translate into changes in the
intrafollicular balance between anagen-maintaining and
catagen-promoting growth factors (e.g., IGF-1 vs. TGFb2).
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Figure 5. P-cadherin (P-cad.) knockdown increases degradation of b-catenin and reduces the expression of b-catenin target genes. (a–c) Significantly reduced
b-catenin immunoreactivity (IR) below Auber’s line (dotted line) following P-cad. silencing. Pooled data from two experiments. ***Po0.0001, Mann–Whitney
test, n¼19–23. (d–g) Significantly increased glycogen synthase kinase 3 b (GSK3b) and phospho-b-catenin (P-b-catenin) IR in the innermost hair matrix (IHM).
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To elucidate these P-cadherin-dependent signals that have an
impact on and/or emanate from the innermost hair matrix,
certainly, is an important future research target. Moreover, the
present study paves way for the development of a potential
new class of human hair growth inhibitors, namely P-cadherin
inhibitory agents, as a previously unreported strategy for the
management of hirsutism.
P-cadherin expression was also demonstrated in retinal
pigment epithelium of mice (Xu et al., 2002) and humans
(Burke et al., 1999). Therefore, it is interesting to note that a
key feature of HJMD patients is progressive macular
degeneration leading to blindness in the third decade of life.
This raises the intriguing, speculative question whether P-
cadherin may have an important role in the—insufficiently
understood—pathogenesis of age-related macular degenera-
tion, the leading cause of blindness in the adult population in
the Western world (Gragoudas et al., 2004).
The effects of P-cadherin silencing in normal adult human
scalp HFs in vitro correspond well to the hair phenotype of
patients with HJMD and EEM syndromes, who characteristically
exhibit an abnormally high percentage of catagen HFs and
show retarded/reduced hair shaft formation (Sprecher et al.,
2001; Bergman et al., 2004). Therefore, our study also provides
a clinically relevant in vitro-surrogate model for studying (a) the
general consequences of P-cadherin loss of function in human
epithelial biology in situ and (b) the pathomechanisms that
underlie the complex and as yet ill-understood hair phenotypes
seen in HJMD and EEM patients.
MATERIALS AND METHODS
Tissue collection
Human anagen VI HFs were isolated from scalp skin obtained from
six patients undergoing routine face-lift surgery (one man and five
women aged 42–59 years; mean age 50 years) after written, informed
consent and adherence to the Declaration of Helsinki Principles.
P-cadherin knockdown
In four HF cultures, HFs were transfected once with human
P-cadherin siRNA (Sigma-Aldrich, Munich, Germany, SA-
SI_Hs02_00332561, 50-CCAAUAUCUGUCCCUGAAA-30) at day 0,
whereas in two additional cultures HFs were transfected twice, i.e.,
at days 0 and 3. HFs treated with control siRNA (scrambled oligos;
Santa Cruz Biotechnology, Santa Cruz, CA, sc-37007) served as
control. After transfection (and between the two transfections in the
two additional cultures mentioned above), HFs were maintained in a
24-well plate with 500 ml William’s E medium (Biochrom, Cam-
bridge, UK) supplemented with 1% L-glutamine (Invitrogen, Paisley,
UK), 0.02% hydrocortisone (Sigma-Aldrich), 0.1% insulin (Sigma-
Aldrich), and 1% antibiotic/antimycotic mixture (Gibco, Karlsruhe,
Germany; Philpott et al., 1990). All reagents required for transfection
were obtained from Santa Cruz Biotechnology (siRNA transfection
reagent, sc-29528; siRNA transfection medium, sc-36868). HF
transfection was performed according to the manufacturer’s protocol
(Santa Cruz Biotechnology).
Human HF and skin organ culture
Normally pigmented anagen VI HFs were microdissected and organ-
cultured under serum-free conditions in insulin- and hydrocortisone-
supplemented William’s E medium (Philpott et al., 1990; Kloepper
et al., 2010). Six HF organ cultures were prepared (each derived
from a separate patient; total HF number in each culture: 52–132).
Two full-thickness human skin organ cultures from two different
patients (aged 58 and 77 years) were also prepared as described
elsewhere (Lu et al., 2007; Bodo et al., 2010).
For each experiment, HFs were equally divided between those
treated with P-cadherin siRNA (test) or scrambled oligos (control).
In one culture, culture medium was also supplemented with 40 mM
lithium chloride (Sigma, Munich, Germany; either as the only
treatment, or 5–7 hours after transfection) or 5mg ml1 TGFb-
neutralizing antibody (monoclonal anti-TGFb1-3 antibody; R&D
systems, Wiesbaden, Germany; either as the only treatment or
simultaneously with the transfection). Lithium chloride was added
only once to the culture medium (5–7 hours after transfection), and
HFs were embedded 24 hours afterward. TGFb-neutralizing anti-
body was added first, 5–7 hours after transfection, and a concentra-
tion of 5mg ml1 was added every day in a 4-day culture period.
Hair shaft length was measured daily using an inverted binocular
microscope (Philpott et al., 1990), and culture medium was replaced
immediately after the transfection and then every other day. On days
2 and 4 (and also on day 3 in the two transfection cultures), samples
of culture medium were taken for measuring the lactate dehydro-
genase (LDH) level as a general cell toxicity parameter in human
skin organ culture (Lu et al., 2007). This showed no significant
increase in the LDH release of P-cadherin-silenced HFs compared
with HFs treated with scrambled oligo controls after a single
transfection, but demonstrated the expected rise in LDH levels after
repeated siRNA treatment (data not shown). This indicates minimal
toxicity after a single transfection, whereas repeated transfection
carries the expected risk of increased toxicity. At 24 hours after the
transfection (on day 1 in the one transfection cultures and on day 4
in the two transfection cultures), 12–25 HFs from each culture were
frozen in liquid nitrogen for RNA extraction and mRNA analysis. The
rest of the HFs in each culture were embedded in Shandon
Cryomatrix (Pittsburgh, PA) and snap-frozen in liquid nitrogen on
day 4 of culture. HFs that were treated with lithium chloride were
embedded 24 hours after the beginning of treatment.
Five to seven 6-mm-thick cryosections of organ-cultured human
HFs were prepared for subsequent immunohistology, and were
stored at 801C until use.
In the two skin organ cultures, 2-mm full-thickness skin punches
were transfected with P-cadherin siRNA and control siRNA at day 0
(six pieces per group) using a similar protocol as that used for HF
organ culture. In one culture, 24 hours after transfection, skin
punches were frozen in liquid nitrogen for RNA extraction and
mRNA analysis. In the second culture, skin punches were embedded
in Shandon Cryomatrix and snap-frozen in liquid nitrogen on day 4
of culture. Cryosections (7 mm thick) of skin punches were cut for
immunohistological staining.
The efficacy of gene silencing was evaluated using P-cadherin-
specific immunohistochemistry and Q-PCR, both in the HF and skin
organ cultures.
Materials and Methods for supplementary data
Immunohistochemistry, apoptosis/proliferation assay, melanin
histochemistry, hair cycle staging, quantitative (immuno)histomor-
phometry, HJMD patient histology, quantitative real-time PCR
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(Q-PCR), transmission electron microscopy, and statistical analysis
can be found in the supplementary materials, online.
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